Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
8.52 USD | -2.07% |
|
-4.92% | -20.92% |
15/07 | Morgan Stanley Cuts Price Target on Vicarious Surgical to $10 From $18, Keeps Equalweight Rating | MT |
29/04 | Transcript : Vicarious Surgical Inc., Q1 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-20.92% | 51.15M | |
+3.65% | 208B | |
+7.66% | 182B | |
+29.31% | 155B | |
+35.70% | 115B | |
+2.93% | 66.52B | |
+15.38% | 53.93B | |
-4.51% | 46.26B | |
-3.83% | 38.22B | |
+6.16% | 36.6B |
- Stock Market
- Equities
- RBOT Stock
- News Vicarious Surgical Inc.
- Morgan Stanley Cuts Price Target on Vicarious Surgical to $10 From $18, Keeps Equalweight Rating